Welcome
-
Home
-
Register
-
Login
-
Help/FAQ
-
0 items
Search
Enter keywords, a title or
a report id number below.
In All Categories
---------------------
Telecom & Computing
Business & Finance
Mfg & Construction
Pharma & Healthcare
Consumer & Retail
Gov & Public Sector
Energy & Transport
Country Reports
Company Reports
---------------------
Transcripts
Advanced
Select a currency for use throughout the site
Australia Dollars
Canada Dollars
Euro
Japan Yen
Sweden Kroner
Switzerland Francs
UK Pounds
US Dollars
Viewing report
Order by Fax
Printer Friendly
PDF Brochure
Send to Friend
Enquire before Buying
|
More
Electronic
Business Strategies for Different Types of Biogenerics
Decision Resources, Inc., Nov 2007, Pages: 32
Description
Table of Contents
Companies Mentioned
Enquire before Buying
Send to a Friend
Companies Mentioned:
- Affymax
- Amgen
- Astellas
- Bioceuticals Arzneimittel
- BioPartners
- Chugai
- Dr. Reddy’s
- Dragon Pharmaceutical
- Eli Lilly
- Eyetech Pharmaceuticals
- Ferring Pharmaceuticals
- Fibrogen
- Genentech
- Hexal Biotech Forschungs
- Hospira
- Johnson & Johnson
- Medice Arzneimittel Pütter
- Merck
- Novartis
- Novo Nordisk
- Ortho Biotech
- OSI Pharmaceuticals
- Pfizer
- Prolong Pharmaceuticals
- Roche
- Sandoz
- Sanofi-Aventis
- Schering-Plough
- Serono
- STADA Arzneimittel
- Takeda
- Valeant Pharmaceuticals
- Wockhardt
- Yamanouchi
Products Mentioned:
- Abseamed
- Apidra
- Aranesp
- Binocrit
- Epoetin alfa Hexal
- Epogen
- Eprex
- Erythropoietin (approved biogeneric)
- Genotropin
- Granocyte/Neutrogin
- Grastim
- Hematide
- Humalog
- Humatrope
- Humulin N
- Humulin R
- Humulin U
- Infergen
- Infergen/Advaferon
- Intron-A
- Lantus
- Levemir
- Lucentis
- Macugen
- Maxomat
- Mircera
- NeoRecormon
- Neulasta
- Neulasta/Neupopeg
- Neupogen
- Norditropin
- Novolin N
- NovoLog/NovoRapid
- Novolon
- Nutropin
- Omnitrope
- Pegasys
- PEG-Intron
- Procrit
- Roferon-A
- Saizen
- Valtropin
- Vioxx
- Wepox
- Wosulin
- Zomacton
Customers who bought this item also bought
A Guide to Biosimilars, Biogenerics and Follow-On Biologics
Toward a Biogenerics Market: The Regulatory Conundrum
Biogenerics 2005: A New Level Of Complexity
Biosimilars, Biogenerics and Follow-On Biologics
Competitor Analysis: Biogenerics & Therapeutic Proteins
The Anemia Market: Biogenerics and Second-Generation Products Drive Change
Biogenerics: Challenges and Promise
The Biogenerics Market Outlook: An Analysis of Market Dynamics, Growth Drivers and Leading Players
Biogenerics: Drivers and Resistors of Market Development
Biogenerics - Global Strategic Business Report
Strategic Analysis of the World Biogenerics Market
Strategies for Biogeneric Success
Top of page
All rights reserved. © Copyright 2009 Research and Markets
0
Terms and conditions
Privacy Policy
Publishers
Employment Opportunities
Site Map
Link to us
Webmaster